A Reverse Distribution Perspective Of The Issues Of

A Reverse Distribution Perspective Of The Issues Of Pharmaceutical Collection The 1 st National Pharmaceutical Product Stewardship Dialogue Meeting June 19 th, 2008 Sacramento, California Mark Harvey Director of Operations EXP Pharmaceutical Services Corp. © 2008 EXP Pharmaceutical Services Corp.

Industry Overview • What is a Reverse Distributor? – Returning Potentially Creditable Pharmaceuticals – Waste Determination and Management at Reverse Distributor’s Facility – Assisting Current Customers in Waste Management and Education by: • Initial training of Pharmacy staff by Reverse Distributor personnel • Processing report data that includes reasons for credit ineligibility • Non-compliance incident reports

Regulatory Challenges – DEA: • Memorandum of Understanding • Allow Bay Area pilot program – USPS: • Packaging & Labeling • Acceptable Materials – State: • MWMA (Medical Waste Management Act) • LTC Homes • SB 966 (signed by Governor Schwarzenegger)

Differing Opinions – Materials Collected: • Non-Controlled Substances • Medical Waste – Type Of Program: • Drop-Off vs. Mail-Back – Type Of Treatment: • Incineration • Hazardous Waste Treatment

Implications –Reduces Teen Pharming –Increases Patient Safety –Environmental Impact –Child and Elder Safety

Partnerships – Waste Water Agencies – City and State Government – County Health – Public/Private Organizations – BAPPG (Bay Area Pollution Prevention Group) – Save The Bay (NGO) – Pharmacies – EPA – USPS – DEA – DPH – DTSC

Questions? Mark Harvey Director of Operations 48021 Warm Springs Blvd Fremont, CA 94539 Phone: 510 -933 -0936 Email: Mark. RH@expworld. com